A Tradition of Innovative Care 

The Division of Vascular and Endovascular Surgery has provided generations of patients with expert evaluation and access to the newest therapies and clinical trials for the treatment of vascular conditions.

National Leaders in Advanced Therapies and Endovascular Treatments

As national leaders in the development of minimally invasive endovascular treatments as well as the surgical management of complex vascular conditions, our skilled surgeons are uniquely equipped to determine the best treatment for each individual patient - whether open surgery or endovascular surgery.

Extensive Experience in All Subspecialties

Our board-certified surgeons are faculty members of Harvard Medical School and have decades of experience managing complex vascular disease. Their extensive expertise spans every vascular subspecialty including aortic aneurysm, carotid disease, lower extremity arterial disease and venous disease.

A History of Innovation

In the Division of Vascular and Endovascular Surgery at BIDMC, innovation is central to patient care. Our surgeons have helped transform the field by developing minimally invasive techniques for treating aortic aneurysms, carotid artery disease and peripheral vascular disease. Our program offers patients a number of innovative treatments, including:

  • Percutaneous AAA repair. We have pioneered the use of totally percutaneous (through the skin) repair for abdominal aortic aneurysms, helping to eliminate the need for incisions and associated complications. We have also helped to develop a real-time 3D visualization system for improved guidance during complex aortic aneurysm repair procedures. Fiber Optic RealShape (FORS) technology provides a picture of devices inside the body without the need for fluoroscopy, reducing radiation for the patient and care team.
  • Limb-sparing endovascular therapy. Our program has among the world's most extensive experience in performing tibial angioplasty, a minimally invasive treatment for critical limb ischemia, which prevents amputations and can lead to improved quality of life.

Commitment to Quality

Our program maintains a steadfast commitment to quality. Our ongoing rigorous analysis of our clinical outcomes ensures that our patients always receive the best possible care. Led by Chief Marc Schermerhorn, MD, the Division of Vascular and Endovascular Surgery actively participates in the Vascular Quality Initiative/Vascular Study Group of New England, which enables us to compare our outcomes to those of other institutions across the region.

Prolific Research

Our active research program includes extensive clinical research focused on patient outcomes and new technologies. In addition, investigators in the Division of Vascular and Endovascular Surgery oversee National Institutes of Health-funded basic science research. As leaders of dozens of clinical trials, our team has made BIDMC one of the most prolific vascular surgery clinical trial sites in the world. Clinical trials test new therapies, including both drugs and procedures, and can provide BIDMC patients with an even wider range of treatment options for vascular conditions. Your vascular surgeon will discuss whether there is a clinical trial that is appropriate for you.

Learn more about Vascular Clinical Trials.